Correspondence | Published:

Gene patents do not hinder academic research

Nature Methods volume 9, page 1039 (2012) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Anonymous. Nat. Methods 9, 931 (2012).

  2. 2.

    Science 322, 198–199 (2008).

  3. 3.

    National Research Council. Reaping the benefits of genomic and proteomic research: intellectual property rights, innovation, and public health (National Academies, Washington, DC, 2006).

  4. 4.

    , & Patents, material transfers and access to research inputs in biomedical research. <> (2005)

  5. 5.

    & Genome Med. 1, 22 (2009).

  6. 6.

    Will gene patents derail the next-generation of genetic technologies?: a reassessment of the evidence suggests not. UMKC Law Rev. 80, 563–606 (2012).

  7. 7.

    II Unblocked future: why gene patents won't hinder whole genome sequencing and personalized medicine. Cardozo Law Rev. 33, 1601–1631 (2012).

Download references

Author information

Affiliations

  1. Biotechnology Industry Organization, Washington, DC, USA.

    • Jim Greenwood

Authors

  1. Search for Jim Greenwood in:

Competing interests

J.G. is president and CEO of the Biotechnology Industry Organization.

Corresponding author

Correspondence to Jim Greenwood.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nmeth.2245

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing